ArticleContemporary oncology (Poznan, Poland)2023

Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing.

Monika Adamska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.